FTSE All-Share
|
5 285,79
|
-44,85
|
-0,84 %
|
Analysen zu FTSE All-Share-Werten
| 01.04.25 | Shell Overweight | JP Morgan Chase & Co. | |
| 31.03.25 | HSBC Holdings Neutral | UBS AG | |
| 31.03.25 | Vodafone Group Buy | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 27.03.25 | HSBC Holdings Buy | Goldman Sachs Group Inc. | |
| 26.03.25 | Diageo Buy | Jefferies & Company Inc. | |
| 26.03.25 | Shell Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.03.25 | Rio Tinto Kaufen | DZ BANK | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | Shell Overweight | JP Morgan Chase & Co. | |
| 26.03.25 | Shell Buy | UBS AG | |
| 26.03.25 | Shell Buy | Jefferies & Company Inc. | |
| 26.03.25 | Shell Outperform | RBC Capital Markets | |
| 25.03.25 | Shell Buy | UBS AG | |
| 25.03.25 | Glencore Outperform | RBC Capital Markets | |
| 25.03.25 | Shell Buy | Goldman Sachs Group Inc. | |
| 25.03.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 25.03.25 | Shell Buy | Jefferies & Company Inc. | |
| 25.03.25 | Shell Outperform | RBC Capital Markets | |
| 25.03.25 | GSK Hold | Deutsche Bank AG | |
| 25.03.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 25.03.25 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.03.25 | London Stock Exchange Buy | UBS AG | |
| 20.03.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 19.03.25 | Shell Buy | Jefferies & Company Inc. | |
| 19.03.25 | BAT Neutral | JP Morgan Chase & Co. | |
| 19.03.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 19.03.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 18.03.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 18.03.25 | Shell Outperform | RBC Capital Markets | |
| 18.03.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 18.03.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | Unilever Underperform | Jefferies & Company Inc. |
HOT STOCKS DER LETZTEN 3 TAGE
| Vodafone Group | 4 |
| AstraZeneca | 4 |
| London Stock Exchange | 3 |
| Diageo | 3 |
| Rio Tinto | 1 |
| BAT | 1 |
| Unilever | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.